AMGN
Amgen Inc.$362.12+0.44% 1D· price as of Jun 30, 8:32 PM+29.74% over 1Y
Compare:AMGN
Mkt Cap
$195.4B
P/E
25.2×
Fwd P/E
15.4×
PEG
1.96
P/B
21.3×
P/S
5.3×
EV/EBITDA
14.2×
Beta
0.42
Div Yield
2.8%
Payout
67.2%
ROE
101.3%
Net Margin
21.0%
Short % Flt
2.3%
Inst. Own
85.2%
52-wk low $269.77$362.1252-wk high $391.29
+34.2% above low-7.5% from high
Seasonality — avg monthly return
Strongest Jan 4.2% · weakest Apr -3.3%Jan
+4.2
Feb
-1.1
Mar
+2.9
Apr
-3.3
May
+1.6
Jun
+0.7
Jul
+3.7
Aug
-0.4
Sep
-2.5
Oct
+3.5
Nov
+2.3
Dec
-0.3
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Amgen Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
AMGN — recent news
Loading headlines…
Quality scorecard
vs Biotechnology · 8 peers · percentile rank
38 / 100
Below average
ROIC12.3%
43
ROE89.1%
100
Gross margin67.2%
14
Operating margin24.7%
14
FCF yield4.2%
43
Net debt / EBITDA2.7×
14
Percentile vs 8 Biotechnology peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.